JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
Notable Analyst Rating Changes 01/31: (FB) (VALE) (AJG) Upgraded; (RF) (PCLN) (VELT) Downgraded
-
Notable Analyst Rating Changes 11/09: (ISIS) (FAST) (MRO) Upgraded; (PSX) (MDRX) (CSCO) Downgraded
-
JPMorgan Downgrades Forest Laboratories (FRX) to Neutral
-
Notable Analyst Rating Changes 04/26: (ROK) (DPS) (APD) Upgraded; (HES) (ABB) (LEAP) Downgraded
-
Notable 52-Week Highs and Lows of the Day 06/03: (SOLR) (FRX) (NFLX) High; (CSCO) (OREX) (RIMM) Low
-
Notable Analyst Rating Changes 06/03: (DRYS) (FRX) (UA) Upgraded; (ALL) (FRO) (FDO) Downgraded
-
JPMorgan Upgrades Forest Laboratories (FRX) to Overweight
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
JPMorgan Upgrades Forest Laboratories (FRX) to Neutral
-
Daily State of the Markets 09/23: Shoulda, Coulda, Woulda?
-
Notable Analyst Rating Changes 07/06: GS, WLT, BP, VLTR Upgraded; DB, AEO, RFMD, AMAT Downgraded
-
Notable Analyst Rating Changes 1/5: RSH, QCOM, BIIB, AXL, More Upgraded; CBY, V, BEXP, COG, CXO, More Downgraded
-
Notable Analyst Rating Changes 12/17: NWSA, UNM, LNC, PTV Upgraded; ADP, AEM, FGXI, OC Downgrades
-
Morning Movers 1/20: RBS and Other UK Banks Slammed, U.S. Banks Follow (RBS, BAC, WFC, C)
-
David Moenning's Daily State of the Markets: 1/20
-
Morning Movers 1/15: Cypress Bioscience (CYPB) Jumps On FDA Okay; Apple (AAPL) Lower on Jobs' Medical Leave
-
David Moenning's Daily State of the Markets: 10/16
-
Notable Analyst Rating Changes 10/07: NOK, ALU, FCX, TU Upgraded; FSLR, SPWR, DIS, IBM, FRX Downgraded
-
JPMorgan Downgrades Forest Laboratories (FRX) to Underweight
-
Pre-Open Movers: MoneyGram (MGI) Sinks On Investment Losses, Manatron (MANA), Lifecore Biomedical (LCBM) Up on Buyouts
